Phase 3 Ixo-Vec Program Advances
-
By
-
Jim Gallagher, senior managing editor
-
May 14, 2026
-
4 min
Original Source(s)
Related Content
Anti-VEGF Gains Ground in PDR
Brolucizumab challenges laser procedure in proliferative diabetic retinopathy management
May 28, 2026
-
4 min
From Babylon to Berlin
Iraqi-born ophthalmologist Hasan Chichan reflects on bridging the divide between modern retina care and humanitarian medicine
May 26, 2026
-
7 min
Refocusing Retinal Imaging
New study looks at extending retinal focus using computational adaptive optics framework
May 26, 2026
-
4 min
